The overexpression of cyclo-oxygenase-2 in chronic periodontitis

Fan Zhang, Steven Engebretson, Rakhi S. Morton, Paul F. Cavanaugh, Kotha Subbaramaiah, Andrew J. Dannenberg

Research output: Contribution to journalArticle

Abstract

Background. The objective of this prospective cross-sectional study was to determine if cyclo-oxygenase-2, or COX-2, is overexpressed in the inflamed gingival tissue of patients diagnosed as having moderate-to-severe chronic periodontitis, or CP. Methods. The authors evaluated clinical measures, crevicular fluid and gingival biopsy specimens from patients with moderate or severe CP (n = 16) and from healthy volunteers (n = 8). Patients were diagnosed as having CP based on clinical attachment loss, or CAL, of at least 5 millimeters at two sites in each quadrant and on evidence of alveolar bone loss as assessed from standard periapical or bite-wing radiographs. Healthy patients exhibited no sites with CAL of more than 2 mm and no evidence of alveolar bone loss. The authors used standard techniques to perform biochemical measures. Results. Levels of interleukin-1 beta, or IL-1β, in crevicular fluid were more than doubled in the CP group (P < .05). The amounts of COX-2 mRNA and protein also were elevated in gingival tissues from subjects with CP compared with those from healthy subjects. To gain further mechanistic insights, the authors conducted in vitro studies. The results showed that lipopolysaccharide and tumor necrosis factor alpha, or TNF-α, induced COX-2 in macrophages, while IL-1β and TNF-α induced COX-2 in oral epithelial cells. Conclusions. Taken together, these results suggest that levels of COX-2 in gingivae reflect clinical measures of periodontitis and gingival inflammation. Clinical Implications. The discovery of increased levels of COX-2 in inflamed gingival tissue suggests that COX-2 represents a pharmacological target for the prevention or treatment of CP.

Original languageEnglish (US)
Pages (from-to)861-867
Number of pages7
JournalJournal of the American Dental Association
Volume134
Issue number7
StatePublished - Jul 2003

Fingerprint

Chronic Periodontitis
Prostaglandin-Endoperoxide Synthases
Alveolar Bone Loss
Interleukin-1
Healthy Volunteers
Gingival Crevicular Fluid
Periodontitis
Gingiva
Bites and Stings
Interleukin-1beta
Lipopolysaccharides
Tumor Necrosis Factor-alpha
Cross-Sectional Studies
Epithelial Cells
Macrophages
Pharmacology
Inflammation
Biopsy
Messenger RNA
Proteins

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Zhang, F., Engebretson, S., Morton, R. S., Cavanaugh, P. F., Subbaramaiah, K., & Dannenberg, A. J. (2003). The overexpression of cyclo-oxygenase-2 in chronic periodontitis. Journal of the American Dental Association, 134(7), 861-867.

The overexpression of cyclo-oxygenase-2 in chronic periodontitis. / Zhang, Fan; Engebretson, Steven; Morton, Rakhi S.; Cavanaugh, Paul F.; Subbaramaiah, Kotha; Dannenberg, Andrew J.

In: Journal of the American Dental Association, Vol. 134, No. 7, 07.2003, p. 861-867.

Research output: Contribution to journalArticle

Zhang, F, Engebretson, S, Morton, RS, Cavanaugh, PF, Subbaramaiah, K & Dannenberg, AJ 2003, 'The overexpression of cyclo-oxygenase-2 in chronic periodontitis', Journal of the American Dental Association, vol. 134, no. 7, pp. 861-867.
Zhang F, Engebretson S, Morton RS, Cavanaugh PF, Subbaramaiah K, Dannenberg AJ. The overexpression of cyclo-oxygenase-2 in chronic periodontitis. Journal of the American Dental Association. 2003 Jul;134(7):861-867.
Zhang, Fan ; Engebretson, Steven ; Morton, Rakhi S. ; Cavanaugh, Paul F. ; Subbaramaiah, Kotha ; Dannenberg, Andrew J. / The overexpression of cyclo-oxygenase-2 in chronic periodontitis. In: Journal of the American Dental Association. 2003 ; Vol. 134, No. 7. pp. 861-867.
@article{6d735631bda645ef8ce092737a2e388d,
title = "The overexpression of cyclo-oxygenase-2 in chronic periodontitis",
abstract = "Background. The objective of this prospective cross-sectional study was to determine if cyclo-oxygenase-2, or COX-2, is overexpressed in the inflamed gingival tissue of patients diagnosed as having moderate-to-severe chronic periodontitis, or CP. Methods. The authors evaluated clinical measures, crevicular fluid and gingival biopsy specimens from patients with moderate or severe CP (n = 16) and from healthy volunteers (n = 8). Patients were diagnosed as having CP based on clinical attachment loss, or CAL, of at least 5 millimeters at two sites in each quadrant and on evidence of alveolar bone loss as assessed from standard periapical or bite-wing radiographs. Healthy patients exhibited no sites with CAL of more than 2 mm and no evidence of alveolar bone loss. The authors used standard techniques to perform biochemical measures. Results. Levels of interleukin-1 beta, or IL-1β, in crevicular fluid were more than doubled in the CP group (P < .05). The amounts of COX-2 mRNA and protein also were elevated in gingival tissues from subjects with CP compared with those from healthy subjects. To gain further mechanistic insights, the authors conducted in vitro studies. The results showed that lipopolysaccharide and tumor necrosis factor alpha, or TNF-α, induced COX-2 in macrophages, while IL-1β and TNF-α induced COX-2 in oral epithelial cells. Conclusions. Taken together, these results suggest that levels of COX-2 in gingivae reflect clinical measures of periodontitis and gingival inflammation. Clinical Implications. The discovery of increased levels of COX-2 in inflamed gingival tissue suggests that COX-2 represents a pharmacological target for the prevention or treatment of CP.",
author = "Fan Zhang and Steven Engebretson and Morton, {Rakhi S.} and Cavanaugh, {Paul F.} and Kotha Subbaramaiah and Dannenberg, {Andrew J.}",
year = "2003",
month = "7",
language = "English (US)",
volume = "134",
pages = "861--867",
journal = "Journal of the American Dental Association",
issn = "0002-8177",
publisher = "American Dental Association",
number = "7",

}

TY - JOUR

T1 - The overexpression of cyclo-oxygenase-2 in chronic periodontitis

AU - Zhang, Fan

AU - Engebretson, Steven

AU - Morton, Rakhi S.

AU - Cavanaugh, Paul F.

AU - Subbaramaiah, Kotha

AU - Dannenberg, Andrew J.

PY - 2003/7

Y1 - 2003/7

N2 - Background. The objective of this prospective cross-sectional study was to determine if cyclo-oxygenase-2, or COX-2, is overexpressed in the inflamed gingival tissue of patients diagnosed as having moderate-to-severe chronic periodontitis, or CP. Methods. The authors evaluated clinical measures, crevicular fluid and gingival biopsy specimens from patients with moderate or severe CP (n = 16) and from healthy volunteers (n = 8). Patients were diagnosed as having CP based on clinical attachment loss, or CAL, of at least 5 millimeters at two sites in each quadrant and on evidence of alveolar bone loss as assessed from standard periapical or bite-wing radiographs. Healthy patients exhibited no sites with CAL of more than 2 mm and no evidence of alveolar bone loss. The authors used standard techniques to perform biochemical measures. Results. Levels of interleukin-1 beta, or IL-1β, in crevicular fluid were more than doubled in the CP group (P < .05). The amounts of COX-2 mRNA and protein also were elevated in gingival tissues from subjects with CP compared with those from healthy subjects. To gain further mechanistic insights, the authors conducted in vitro studies. The results showed that lipopolysaccharide and tumor necrosis factor alpha, or TNF-α, induced COX-2 in macrophages, while IL-1β and TNF-α induced COX-2 in oral epithelial cells. Conclusions. Taken together, these results suggest that levels of COX-2 in gingivae reflect clinical measures of periodontitis and gingival inflammation. Clinical Implications. The discovery of increased levels of COX-2 in inflamed gingival tissue suggests that COX-2 represents a pharmacological target for the prevention or treatment of CP.

AB - Background. The objective of this prospective cross-sectional study was to determine if cyclo-oxygenase-2, or COX-2, is overexpressed in the inflamed gingival tissue of patients diagnosed as having moderate-to-severe chronic periodontitis, or CP. Methods. The authors evaluated clinical measures, crevicular fluid and gingival biopsy specimens from patients with moderate or severe CP (n = 16) and from healthy volunteers (n = 8). Patients were diagnosed as having CP based on clinical attachment loss, or CAL, of at least 5 millimeters at two sites in each quadrant and on evidence of alveolar bone loss as assessed from standard periapical or bite-wing radiographs. Healthy patients exhibited no sites with CAL of more than 2 mm and no evidence of alveolar bone loss. The authors used standard techniques to perform biochemical measures. Results. Levels of interleukin-1 beta, or IL-1β, in crevicular fluid were more than doubled in the CP group (P < .05). The amounts of COX-2 mRNA and protein also were elevated in gingival tissues from subjects with CP compared with those from healthy subjects. To gain further mechanistic insights, the authors conducted in vitro studies. The results showed that lipopolysaccharide and tumor necrosis factor alpha, or TNF-α, induced COX-2 in macrophages, while IL-1β and TNF-α induced COX-2 in oral epithelial cells. Conclusions. Taken together, these results suggest that levels of COX-2 in gingivae reflect clinical measures of periodontitis and gingival inflammation. Clinical Implications. The discovery of increased levels of COX-2 in inflamed gingival tissue suggests that COX-2 represents a pharmacological target for the prevention or treatment of CP.

UR - http://www.scopus.com/inward/record.url?scp=0142089751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142089751&partnerID=8YFLogxK

M3 - Article

C2 - 12892443

AN - SCOPUS:0142089751

VL - 134

SP - 861

EP - 867

JO - Journal of the American Dental Association

JF - Journal of the American Dental Association

SN - 0002-8177

IS - 7

ER -